期刊
CLINICAL LIPIDOLOGY
卷 6, 期 4, 页码 447-462出版社
FUTURE MEDICINE LTD
DOI: 10.2217/CLP.11.25
关键词
drug interactions; fibrates; fish oil; guidelines; HIV-associated dyslipidemia; hypertriglyceridemia; niacin; statins
资金
- ACTG
- National Institute of Allergy and Infectious Diseases [AI069532]
- Gilead
- GlaxoSmithKline
- Kowa
- Pfizer
- Tibotec
Antiretroviral therapy has dramatically increased survival for HIV-infected individuals. As this population lives longer, coronary heart disease has become an important comorbid condition. Dyslipidemia in HIV-infected individuals is a complex condition, with multiple contributing factors including the HIV virus itself, individual genetic characteristics and antiretroviral therapy-induced metabolic changes. Effective management of dyslipidemia in this population is essential to reduce cardiovascular risk but presents multiple challenges due to interactions between antiretroviral therapy agents and lipid-lowering medications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据